PRODUCTS
AIVITA AMG
AIVITA AMG
Large NGS Panel
Driving the Future of Precision Medicine
With outstanding automated workflows, AI-driven analysis, and high-performance equipment, we elevate cancer screening and personalized treatment to new heights, providing medical institutions and patients with a faster, more accurate, and standardized testing experience.
Illumina's NGS platform has become the gold standard in genetic testing, capable of detecting even the smallest genetic variations to provide scientific evidence for cancer risk assessment and treatment decision-making. However, genetic testing requires more than a single technology. Enhancing testing efficiency, reducing human error, and accelerating report generation are critical challenges.
Illumina's NGS platform has become the gold standard in genetic testing, capable of detecting even the smallest genetic variations to provide scientific evidence for cancer risk assessment and treatment decision-making. However, genetic testing requires more than a single technology. Enhancing testing efficiency, reducing human error, and accelerating report generation are critical challenges.
AIVITA AMG Features
52% Reduction in Testing Time
%20(1).png)
50% Less Workforce Requirement
99% Accuracy Improvement
%20(1).png)
Supports Large NGS Panels
AIVITA AMG Workflow
%20(1).png)
The AIVITA AMG Workflow optimizes the genetic testing process through automation, covering sample processing, nucleic acid extraction, library preparation, gene sequencing, and data analysis. Automated nucleic acid extractors, liquid handling systems, and library purification machines enhance testing accuracy and efficiency. The workflow supports cancer and genetic disease screening with the BRCA Screening Kit , while quality control is ensured through Quantus and Qseq100, verifying DNA sample standards. Finally, DataSense integrates sequencing data to ensure accuracy and generate reliable clinical reports.
